| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/30/2002 | US6379668 Therapy for autoimmune disease |
| 04/30/2002 | US6379665 Therapy for rheumatic diseases; antiarthritic agents |
| 04/30/2002 | US6379662 Human interleukin variation |
| 04/30/2002 | US6379661 Pharmaceutical compositions comprising pluripotent granulocyte colony-stimulating factor |
| 04/30/2002 | US6379624 Tube, first end of which is designed as fitting for connection to pipette and second end of which has opening designed so as to taper conically |
| 04/30/2002 | US6379379 Stent with smooth ends |
| 04/30/2002 | CA2360049A1 Assays for identifying phosphatase inhibitors |
| 04/30/2002 | CA2196207C Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 04/30/2002 | CA2176929C Vaccine against mumps containing a jeryl-lynn virus strain |
| 04/30/2002 | CA2151045C Platelet-activating factor acetylhydrolase |
| 04/30/2002 | CA2107804C Newly characterised oxalate oxidase and uses therefor |
| 04/30/2002 | CA2071908C Antibody antagonists of human interleukin-4 |
| 04/30/2002 | CA2064689C Stabilized protein or peptide conjugates |
| 04/30/2002 | CA2020247C Antibodies reactive with human carcinomas |
| 04/27/2002 | CA2321944A1 Enhancement of freezing tolerance in transgenic strawberry |
| 04/25/2002 | WO2002033412A1 Bio-support and preparing method of the same |
| 04/25/2002 | WO2002033409A1 Support for immobilizing nucleic acid |
| 04/25/2002 | WO2002033128A2 Multiplex quantification of nucleic acids in diseased cells |
| 04/25/2002 | WO2002033126A2 Solid support assay systems and methods utilizing non-standard bases |
| 04/25/2002 | WO2002033119A2 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 04/25/2002 | WO2002033116A2 Nucleic acid ligands to the prostate specific membrane antigen |
| 04/25/2002 | WO2002033110A2 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
| 04/25/2002 | WO2002033109A2 Fermentation method for production of heterologous gene products in lactic acid bacteria |
| 04/25/2002 | WO2002033107A2 Plant cell death system |
| 04/25/2002 | WO2002033106A2 Plant cell death system |
| 04/25/2002 | WO2002033105A2 Reducing oxidative stress of plants by increasing glutathione content |
| 04/25/2002 | WO2002033104A2 Antibiotic-based gene regulation system |
| 04/25/2002 | WO2002033103A2 Non-human mammal with modified pacap type i receptor |
| 04/25/2002 | WO2002033102A1 Receptor mediated activation of heterotrimeric g-proteins |
| 04/25/2002 | WO2002033101A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 04/25/2002 | WO2002033100A2 Regulation of human adenylate cyclase, type iv |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002033098A1 Process for producing viral rna polymerase |
| 04/25/2002 | WO2002033097A2 Regulation of human sulfotransferase |
| 04/25/2002 | WO2002033096A2 Regulation of human serine-threonine protein kinase |
| 04/25/2002 | WO2002033095A2 Regulation of human serine-threonine protein kinase |
| 04/25/2002 | WO2002033092A1 Gene sp17 inhibiting lesion formation in plant and utilization thereof |
| 04/25/2002 | WO2002033091A1 Manipulation of flowering and plant architecture |
| 04/25/2002 | WO2002033090A2 Pharmaceutical preparations and methods for inhibiting tumors |
| 04/25/2002 | WO2002033089A2 Ixodes scapularis tissue factor pathway inhibitor |
| 04/25/2002 | WO2002033088A2 Human carboxypeptidase, scramblase, and protocadherin family members and uses thereof |
| 04/25/2002 | WO2002033087A2 Proteins and nucleic acids encoding same |
| 04/25/2002 | WO2002033086A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/25/2002 | WO2002033085A2 Wisp polypeptides and therapeutical applications thereof |
| 04/25/2002 | WO2002033084A2 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family |
| 04/25/2002 | WO2002033083A2 Methods of using a human il-17-related polypeptide to treat disease |
| 04/25/2002 | WO2002033082A1 Novel disease-associated gene and use thereof |
| 04/25/2002 | WO2002033081A2 Veterinary immunisation vectors comprising nucleic acid sequences encoding variants of non-human c3d polypeptides |
| 04/25/2002 | WO2002033080A2 Regulation of human netrin binding membrane receptor unc5h-1 |
| 04/25/2002 | WO2002033079A2 Human g-protein coupled receptor and uses thereof |
| 04/25/2002 | WO2002033078A1 A novel-polypeptide, a proliferating cell antigen p120-51.59 and the polynucleotide encoding the polypeptide |
| 04/25/2002 | WO2002033077A1 Novel polypeptide--- a regulatory protein 10.01 being related to human development and polynucleotide encoding it |
| 04/25/2002 | WO2002033076A1 Novel polypeptide - the eukaryotic transcript factor 17.38 and polynucleotide encoding it |
| 04/25/2002 | WO2002033075A1 Novel polypeptide--- a human sialyl:transferase (hst30-1)11.99 and polynucleotide encoding it |
| 04/25/2002 | WO2002033074A1 Artificial protein having potentiated immunogenicity of epitope |
| 04/25/2002 | WO2002033067A2 Regulation of promoter activity using a polypeptide isolated from lactococcus lactis |
| 04/25/2002 | WO2002033066A1 A combined electroporation and microinjection method for the penetration of lipid bilayer membranes |
| 04/25/2002 | WO2002033063A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis |
| 04/25/2002 | WO2002033062A1 REGULATION OF HUMAN ACYL-CoA DEHYDROGENASE |
| 04/25/2002 | WO2002033060A2 Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 04/25/2002 | WO2002033059A2 Gnk interacting amino acid decarboxylase and methods of use thereof |
| 04/25/2002 | WO2002033058A2 Novel cysteine proteases and uses thereof |
| 04/25/2002 | WO2002033057A2 Cytochrome p450 monooxygenases consisting of thermophilic bacteria |
| 04/25/2002 | WO2002033054A1 POLYβ2 KNOCKOUT ANIMALS |
| 04/25/2002 | WO2002033051A1 A plant autophagy gene |
| 04/25/2002 | WO2002033049A1 Human tuberoinfundibular peptide of 39 residues |
| 04/25/2002 | WO2002033045A2 Oligonucleotide - facilitated coalescence |
| 04/25/2002 | WO2002033041A2 Production of bovine lysozyme by plant viral vectors |
| 04/25/2002 | WO2002032962A2 Compositions of human proteins and method of use thereof |
| 04/25/2002 | WO2002032961A2 Novel polypeptides and nucleic acids encoding same |
| 04/25/2002 | WO2002032960A2 Methods of selecting compounds for modulation of bladder function |
| 04/25/2002 | WO2002032958A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 04/25/2002 | WO2002032955A1 Human gene critical to fertility |
| 04/25/2002 | WO2002032954A2 Phosphorylation modifications of apoptin |
| 04/25/2002 | WO2002032953A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 04/25/2002 | WO2002032952A1 A novel polypeptide, a human kinesin light chain 62.92 and the polynucleotide encoding the polypeptide |
| 04/25/2002 | WO2002032951A1 A novel polypeptide, a f-box protein 44.33 and the polynucleotide encoding the polypeptide |
| 04/25/2002 | WO2002032950A1 A novel polypeptide-homo dna-dependent 2-hydroxy acid dehydrogenase family protein 26.29 and polynucleotide encoding said polypeptide |
| 04/25/2002 | WO2002032949A1 A novel polypeptide-homo macro-protein 81 and polynucleotide encoding said polypeptide |
| 04/25/2002 | WO2002032948A1 A novel polypeptide-homo macro-protein 10.12 and polynucleotide encoding said polypeptide |
| 04/25/2002 | WO2002032947A1 Transgenic plants |
| 04/25/2002 | WO2002032945A2 Haemophilus influenzae basb206 gene and protein |
| 04/25/2002 | WO2002032944A2 Basb208 nucleotide and amino acid sequences from haemophilus influenzae |
| 04/25/2002 | WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 04/25/2002 | WO2002032939A2 Secreted proteins and their uses |
| 04/25/2002 | WO2002032938A2 Regulation of human pgc-1-like protein |
| 04/25/2002 | WO2002032937A2 Neuromedin u delta |
| 04/25/2002 | WO2002032925A2 Protein scaffolds for antibody mimics and other binding proteins |
| 04/25/2002 | WO2002032923A2 Improved formulations using heat shock/stress protein-peptide complexes |
| 04/25/2002 | WO2002032921A1 Antisense modulation of apaf-1 expression |
| 04/25/2002 | WO2002032568A1 Particulate support for separation/purification or extraction and process for producing the same |
| 04/25/2002 | WO2002032461A2 Protein c or activated protein c-like molecules |
| 04/25/2002 | WO2002032419A2 Methods for modulating bladder function |
| 04/25/2002 | WO2002032378A2 Fusion cells and cytokine compositions for treatment of disease |
| 04/25/2002 | WO2002032291A2 Imaging of enzymatic activity |
| 04/25/2002 | WO2002032288A2 Cd38 modulated chemotaxis |
| 04/25/2002 | WO2001098506A3 Methods and means for regulation of gene expression |
| 04/25/2002 | WO2001093805A3 FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS |
| 04/25/2002 | WO2001091728A3 Nanoemulsion formulations |
| 04/25/2002 | WO2001090374A3 26493, a human mutt dgtpase family member and uses thereof |